We serve Chemical Name:5-methyl-2,3-dihydro-1H-inden-4-ol CAS:20294-31-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-methyl-2,3-dihydro-1H-inden-4-ol
CAS.NO:20294-31-9
Synonyms:5-METHYL-INDAN-4-OL;5-methyl-4-indanol;2,3-dihydro-5-methyl-1H-inden-4-ol;EINECS 243-704-5
Molecular Formula:C10H12O
Molecular Weight:148.20200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:253.6ºC at 760 mmHg
Density:1.112g/cm3
Index of Refraction:1.592
PSA:20.23000
Exact Mass:148.08900
LogP:2.18930
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-METHYL-INDAN-4-OL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 243-704-5 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 243-704-5 Use and application,5-methyl-4-indanol technical grade,usp/ep/jp grade.
Related News: Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. 5-methyl-2,3-dihydro-1H-inden-4-ol manufacturer Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov. 5-methyl-2,3-dihydro-1H-inden-4-ol supplier Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. 5-methyl-2,3-dihydro-1H-inden-4-ol vendor Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. 5-methyl-2,3-dihydro-1H-inden-4-ol factory Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov.
